A significant gap in the field of cancer research is the lack of unbiased, genome-wide studies describing how activated Notch regulates the genomes of cancer cells. We propose to begin to fill this gap by elucidating how activated Notchl (ICNI) interacts with the genomes of T-ALL cells to support leukemia cell growth. We will address this central issue in T-ALL pathogenesis by pursuing the following two specific aims:
Aim 1. To determine how Notchl transactivates target genes Current models for Notch regulation of target genes have been based on analyses of only a few genes (e.g., i-ies1) in diverse cellular contexts. Our preliminary data suggest that individual Notchl binding sites show differential sensitivity to y-secretase inhibitors (GSls), a characteristic that may define dynamic NREs and which points to an unexpected pool of GSI-refractory chromatin-associated Notchl. In this aim, we will first use ChlP-Seq to determine the GSI-sensitivity of chromatin-associated Notchl on a genome-wide basis. Then, with a full set of robust target genes and GSI-sensitive Notchl binding sites in hand, we will test and refine models of Notchl regulation of gene expression in T-ALL cells. We anticipate that these studies will illuminate fundamental mechanisms of target gene regulation by Notch and reveal new opportunities for therapeutic targeting ofthe Notch pathway.
Aim 2. To determine the contributions of cis-regulatory co-factors to Notchl target gene expression Motif analysis carried out in human and murine T-ALL cells showed that Notchl genomic binding sites are often flanked by motifs for Runx factors or Ets factors, or overlap precisely with binding sites for Znf143. In preliminary data, we have observed that Runx factors and Ets factors appear to co-regulate important Notchl target genes such as iL7R that contribute to the growth and survival of T-ALL cells. We will expand upon these data to study how Ets and Runx factors co-regulate key target genes, and will also elucidate the pervasive, but complex relationship of Notchl and Znf143. Together, the work described in these two aims will substantially advance our understanding of the molecular pathogenesis of T-ALL, and in doing so create new opportunities for targeting of the Notch pathway in cancer and in other forms of disease related to dysregulated Notch signaling.

Public Health Relevance

; Notch transforms cells by activating gene expression, yet little is know about details of how this occurs. The project will determine how Notchl regulates the genomes of T-ALL cells, both in general and with specific genes and co-factors. In doing so, this project will uncover molecular mechanisms that will lead to new diagnostic and therapeutic opportunities in T-ALL and other Notch-related cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-J)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Yashiro-Ohtani, Yumi; Wang, Hongfang; Zang, Chongzhi et al. (2014) Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Proc Natl Acad Sci U S A 111:E4946-53
Arnett, Kelly L; Blacklow, Stephen C (2014) Analyzing the nuclear complexes of Notch signaling by electrophoretic mobility shift assay. Methods Mol Biol 1187:231-45
Wang, Hongfang; Zang, Chongzhi; Taing, Len et al. (2014) NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proc Natl Acad Sci U S A 111:705-10
Dail, Monique; Wong, Jason; Lawrence, Jessica et al. (2014) Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia. Nature 513:512-6
Gerhardt, Dawson M; Pajcini, Kostandin V; D'altri, Teresa et al. (2014) The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes Dev 28:576-93
Stoeck, Alexander; Lejnine, Serguei; Truong, Andrew et al. (2014) Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov 4:1154-67
Tiyanont, Kittichoat; Wales, Thomas E; Siebel, Christian W et al. (2013) Insights into Notch3 activation and inhibition mediated by antibodies directed against its negative regulatory region. J Mol Biol 425:3192-204
Andrawes, Marie Blanke; Xu, Xiang; Liu, Hong et al. (2013) Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1. J Biol Chem 288:25477-89
Chiang, Mark Y; Shestova, Olga; Xu, Lanwei et al. (2013) Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells. Blood 121:905-17
Blacklow, Stephen C (2013) Refining a Jagged edge. Structure 21:2100-1

Showing the most recent 10 out of 38 publications